{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:08:48Z","timestamp":1789402128661,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Research Project of Anhui Educational Committee","award":["No. 2024AH051246"],"award-info":[{"award-number":["No. 2024AH051246"]}]},{"name":"the Anhui Province Key Laboratory of Immunology in Chronic Diseases","award":["No. KLICD-2023-D3"],"award-info":[{"award-number":["No. KLICD-2023-D3"]}]},{"name":"the Anhui Provincial Key Research and Development Project","award":["No. 202304295107020088"],"award-info":[{"award-number":["No. 202304295107020088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01450-9","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:26:35Z","timestamp":1789356395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic study of IL-17 inhibitors in alleviating inflammation in ankylosing spondylitis by regulating Treg cell function through modulation of the Ahr signaling pathway"],"prefix":"10.1007","volume":"39","author":[{"given":"Chao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihong","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengxiao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"1","key":"1450_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9\u201325. https:\/\/doi.org\/10.1007\/s10238-021-00728-6.","journal-title":"Clin Exp Med"},{"key":"1450_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119269","volume":"340","author":"M Ma","year":"2025","unstructured":"Ma M, Yang Z, Li K, Yang L, Chen B, Chen M, et al. Molecular insights into the therapeutic mechanisms of Bushen-Qiangdu-Zhilv decoction for ankylosing spondylitis. J Ethnopharmacol. 2025;340:119269. https:\/\/doi.org\/10.1016\/j.jep.2024.119269.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1450_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41678","volume":"11","author":"Y Liu","year":"2025","unstructured":"Liu Y, Shen Y, Ding H, He D, Cheng P, Wu X, et al. T-bet(+)ILC3 in peripheral blood is increased in the ankylosing spondylitis with high disease activity. Heliyon. 2025;11(1):e41678. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41678.","journal-title":"Heliyon"},{"issue":"3","key":"1450_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/1744666x.2022.2038134","volume":"18","author":"R Mohanakrishnan","year":"2022","unstructured":"Mohanakrishnan R, Beier S, Deodhar A. Tofacitinib for the treatment of active ankylosing spondylitis in adults. Expert Rev Clin Immunol. 2022;18(3):273\u201380. https:\/\/doi.org\/10.1080\/1744666x.2022.2038134.","journal-title":"Expert Rev Clin Immunol"},{"key":"1450_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.814278","volume":"12","author":"J Jiang","year":"2021","unstructured":"Jiang J, Zhan X, Liang T, Chen L, Huang S, Sun X, et al. Dysregulation of SAA1, TUBA8 and monocytes are key factors in ankylosing spondylitis with femoral head necrosis. Front Immunol. 2021;12:814278. https:\/\/doi.org\/10.3389\/fimmu.2021.814278.","journal-title":"Front Immunol"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/annrheumdis-2020-eular.5121","volume":"79","author":"T Ding","year":"2020","unstructured":"Ding T, Wu R, Xue H, Li XF, Wang C. AB0028&x2005; Imbalances of TH17\/TREG in cardiovascular events of patients with ankylosing spondylitis. Ann Rheum Dis. 2020;79:1317. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.5121.","journal-title":"Ann Rheum Dis"},{"key":"1450_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02151","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie J, Wang Z, Wang W. Semaphorin 4D induces an imbalance of Th17\/Treg cells by activating the aryl hydrocarbon receptor in ankylosing spondylitis. Front Immunol. 2020;11:2151. https:\/\/doi.org\/10.3389\/fimmu.2020.02151.","journal-title":"Front Immunol"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bone.2018.01.027","volume":"110","author":"P Shukla","year":"2018","unstructured":"Shukla P, Mansoori MN, Singh D. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions. Bone. 2018;110:84\u201395. https:\/\/doi.org\/10.1016\/j.bone.2018.01.027.","journal-title":"Bone"},{"issue":"4","key":"1450_CR9","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.3892\/etm.2020.8981","volume":"20","author":"BA Chis\u0103l\u0103u","year":"2020","unstructured":"Chis\u0103l\u0103u BA, Cr\u00eengu\u0219 LI, Vreju FA, P\u00e2rv\u0103nescu CD, Firulescu SC, Dinescu \u0218C, et al. New insights into IL-17\/IL-23 signaling in ankylosing spondylitis (Review). Exp Ther Med. 2020;20(4):3493\u20137. https:\/\/doi.org\/10.3892\/etm.2020.8981.","journal-title":"Exp Ther Med"},{"key":"1450_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8316106","volume":"2022","author":"Z Cao","year":"2022","unstructured":"Cao Z, Guo J, Li Q, Li Y, Wu J. Optimal biologic drugs for the treatment of ankylosing spondylitis: results from a network meta-analysis and network metaregression. BioMed Res Int. 2022;2022:8316106. https:\/\/doi.org\/10.1155\/2022\/8316106.","journal-title":"BioMed Res Int"},{"key":"1450_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1010572","volume":"13","author":"ZY Song","year":"2022","unstructured":"Song ZY, Yuan D, Zhang SX. Role of the microbiome and its metabolites in ankylosing spondylitis. Front Immunol. 2022;13:1010572. https:\/\/doi.org\/10.3389\/fimmu.2022.1010572.","journal-title":"Front Immunol"},{"issue":"12","key":"1450_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.927","volume":"8","author":"B Liu","year":"2019","unstructured":"Liu B, Yang L, Cui Z, Zheng J, Huang J, Zhao Q, et al. Anti-TNF-\u03b1 therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice. Microbiol Open. 2019;8(12):e927. https:\/\/doi.org\/10.1002\/mbo3.927.","journal-title":"Microbiol Open"},{"key":"1450_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102708","volume":"98","author":"M Peng","year":"2026","unstructured":"Peng M, Sun H. The indole-brain connection: neuroimmune mechanisms and therapy. Curr Opin Immunol. 2026;98:102708. https:\/\/doi.org\/10.1016\/j.coi.2025.102708.","journal-title":"Curr Opin Immunol"},{"key":"1450_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1057555","volume":"13","author":"F Riaz","year":"2022","unstructured":"Riaz F, Pan F, Wei P. Aryl hydrocarbon receptor: the master regulator of immune responses in allergic diseases. Front Immunol. 2022;13:1057555. https:\/\/doi.org\/10.3389\/fimmu.2022.1057555.","journal-title":"Front Immunol"},{"key":"1450_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104513","volume":"151","author":"C Shi","year":"2020","unstructured":"Shi C, Zhang H, Wang X, Jin B, Jia Q, Li Y, et al. Cinnamtannin D1 attenuates autoimmune arthritis by regulating the balance of Th17 and treg cells through inhibition of aryl hydrocarbon receptor expression. Pharmacol Res. 2020;151:104513. https:\/\/doi.org\/10.1016\/j.phrs.2019.104513.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1450_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/art.1780300310","volume":"30","author":"K Mikecz","year":"1987","unstructured":"Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB\/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 1987;30(3):306\u201318. https:\/\/doi.org\/10.1002\/art.1780300310.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1450_CR17","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.celrep.2017.10.114","volume":"21","author":"J Ye","year":"2017","unstructured":"Ye J, Qiu J, Bostick JW, Ueda A, Schjerven H, Li S, et al. The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells. Cell Rep. 2017;21(8):2277\u201390. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.114.","journal-title":"Cell Rep"},{"issue":"9","key":"1450_CR18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.1915","volume":"11","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol. 2010;11(9):846\u201353. https:\/\/doi.org\/10.1038\/ni.1915.","journal-title":"Nat Immunol"},{"issue":"12","key":"1450_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","volume":"15","author":"J Sieper","year":"2019","unstructured":"Sieper J, Poddubnyy D, Miossec P. The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol. 2019;15(12):747\u201357. https:\/\/doi.org\/10.1038\/s41584-019-0294-7.","journal-title":"Nat Rev Rheumatol"},{"key":"1450_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176401","author":"H Tsukazaki","year":"2020","unstructured":"Tsukazaki H, Kaito T. The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21176401.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1450_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02500-8","volume":"11","author":"X Coumoul","year":"2026","unstructured":"Coumoul X, Barouki R, Esser C, Haarmann-Stemmann T, Lawrence BP, Lehmann J, et al. The aryl hydrocarbon receptor: structure, signaling, physiology and pathology. Signal Transduct Target Ther. 2026;11(1):20. https:\/\/doi.org\/10.1038\/s41392-025-02500-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1450_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03601-z","volume":"27","author":"J Yang","year":"2025","unstructured":"Yang J, Lee BW, Park Y, Ju JH, Kim WU, Park SH, et al. Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience. Arthritis Res Ther. 2025;27(1):135. https:\/\/doi.org\/10.1186\/s13075-025-03601-z.","journal-title":"Arthritis Res Ther"},{"key":"1450_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x261424367","volume":"18","author":"YS Jung","year":"2026","unstructured":"Jung YS, Cho SK, Choi SR, Jung SY, Sung YK. Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study. Ther Adv Musculoskelet Dis. 2026;18:1759720x261424367. https:\/\/doi.org\/10.1177\/1759720x261424367.","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01450-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:02:00Z","timestamp":1789401720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01450-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01450-9","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"139"}}